Chongqing, China
Chongqing, China
Cost Of Living
Undergraduate Fees International Students
Post Graduate Fees International Students
Gaoxing Luo is a renowned researcher in the field of medical sciences, particularly known for his work in immunology and... View More
Gaoxing Luo is a renowned researcher in the field of medical sciences, particularly known for his work in immunology and biomedical research. His contributions have made a significant impact on the study of immune system disorders and cancer research. As an alumnus of AMU, Gaoxing has played an instrumental role in advancing China’s medical research landscape. His work has been published in leading international journals, and he has contributed to major breakthroughs in cell biology and immunotherapy. Gaoxing's research has not only helped in understanding the human immune system but also paved the way for developing more targeted and effective treatments for various chronic diseases. View Less
Fei Dai is another distinguished alumnus of AMU, having gained international recognition for his groundbreaking research... View More
Fei Dai is another distinguished alumnus of AMU, having gained international recognition for his groundbreaking research in the field of molecular biology. His expertise lies in studying the genetic basis of several hereditary diseases. Throughout his career, Dai has collaborated with major medical research institutions, working to decode the human genome and its impact on genetic disorders. His contributions have expanded the scope of personalized medicine, providing valuable insights into how genetics influence treatment outcomes. Dai has earned numerous accolades for his work and continues to inspire the next generation of researchers at AMU and beyond. View Less
Yujing Huang is an alumnus of AMU who has made significant strides in the field of neuroscience. Specializing in neurode... View More
Yujing Huang is an alumnus of AMU who has made significant strides in the field of neuroscience. Specializing in neurodegenerative diseases like Alzheimer's and Parkinson's, Huang's work focuses on understanding the molecular mechanisms underlying these conditions. He has been instrumental in developing experimental models that help predict the progression of these diseases, thereby assisting in the creation of targeted therapies. Huang’s commitment to advancing neuroscience research has earned him several prestigious awards, and he continues to collaborate with international institutions to further the understanding of brain health. His contributions have been crucial in the development of novel treatments for neurodegenerative diseases. View Less
Bing Ni is a notable alumnus of AMU, particularly known for his work in medical research and clinical medicine. With a f... View More
Bing Ni is a notable alumnus of AMU, particularly known for his work in medical research and clinical medicine. With a focus on oncology, Ni’s research centers around the molecular biology of cancer and the development of new therapeutic approaches for cancer patients. His innovative research has led to the development of promising cancer treatments that are currently in clinical trials. Ni has also contributed to numerous research papers published in top medical journals and is considered an expert in his field. His work continues to provide valuable insights into cancer biology and treatment, making him a key figure in the global fight against cancer. View Less
Li Wei is a leading researcher and practitioner in the field of cardiovascular medicine, specializing in heart disease a... View More
Li Wei is a leading researcher and practitioner in the field of cardiovascular medicine, specializing in heart disease and its various clinical applications. As an alumnus of AMU, Wei has been at the forefront of several studies aimed at improving cardiovascular health outcomes through better diagnosis and treatment techniques. He has contributed to the development of novel therapies for heart disease and has been involved in large-scale clinical trials aimed at understanding heart disease's genetic factors. His work has been recognized internationally, and he continues to be an influential figure in cardiovascular research, having earned numerous research grants and awards for his work. View Less
Tianyu Zhang is a notable alumnus in the field of pharmaceutical sciences. He has focused his research on drug discovery... View More
Tianyu Zhang is a notable alumnus in the field of pharmaceutical sciences. He has focused his research on drug discovery and development, particularly the creation of new classes of antibiotics and antiviral medications. Zhang’s work has been instrumental in the fight against antibiotic-resistant bacteria, which has become a global health crisis. He has collaborated with various pharmaceutical companies to bring innovative therapies to market and has authored several key publications in the field. His contributions have significantly influenced the pharmaceutical industry, and his research continues to shape future advancements in drug development and public health. View Less
Jian Li is a prominent alumnus of AMU who has made significant contributions to the field of public health, focusing on ... View More
Jian Li is a prominent alumnus of AMU who has made significant contributions to the field of public health, focusing on epidemiology and disease prevention. His work has primarily centered on the prevention of infectious diseases in rural and underdeveloped areas, where healthcare access is limited. Li’s extensive research in disease transmission has led to several public health initiatives in China and internationally, particularly in controlling the spread of infectious diseases such as tuberculosis and HIV. He has worked closely with the World Health Organization (WHO) and other international organizations to promote global health standards and improve healthcare systems in underserved regions. View Less
Ming Zhang is an internationally recognized researcher in the field of biomedical engineering. Zhang’s expertise lies ... View More
Ming Zhang is an internationally recognized researcher in the field of biomedical engineering. Zhang’s expertise lies in developing medical technologies and devices that have improved the accuracy and effectiveness of diagnostic tools. His work in imaging technology has led to the development of advanced medical equipment used in hospitals worldwide. Zhang has published extensively in the field of medical technology, particularly in the application of AI and machine learning for diagnostic purposes. His work continues to have a major impact on healthcare, helping to make medical diagnoses more efficient and accessible to populations around the world. View Less
Shan Wu is a renowned alumnus of AMU, specializing in neurosurgery. Wu has dedicated much of his career to advancing sur... View More
Shan Wu is a renowned alumnus of AMU, specializing in neurosurgery. Wu has dedicated much of his career to advancing surgical techniques and technologies to treat brain and spinal cord disorders. His contributions to minimally invasive surgery have greatly improved the outcomes of neurosurgical procedures. Through his work, Wu has developed innovative approaches to treating patients with brain tumors, traumatic brain injuries, and spinal cord injuries. His research and practice have earned him recognition in global medical communities, and he continues to be a leader in advancing neurosurgical practices through his work with patients and medical institutions worldwide. View Less
Zhen Liu, an esteemed alumnus of AMU, is recognized for his contributions to the field of regenerative medicine. His res... View More
Zhen Liu, an esteemed alumnus of AMU, is recognized for his contributions to the field of regenerative medicine. His research focuses on the use of stem cells to repair damaged tissues and organs, an area of increasing importance in medical science. Liu has pioneered several stem cell therapies that show promise in treating conditions such as liver failure and spinal cord injuries. His work has been published in leading scientific journals and has attracted funding from top research organizations. Liu’s breakthroughs have placed him at the forefront of regenerative medicine, and his innovations continue to influence the direction of medical treatments worldwide. View Less
The below information is required while
completing the university application :
Admission requirements for the Bachelor's programs at Army Medical University (AMU), based on general guidelines from similar institutions in China:
Educational Qualifications: Applicants must have completed senior high school (10+2) or its equivalent, with a strong background in science subjects such as Biology, Chemistry, Physics, Mathematics, and English.
Age Limit: Candidates should be between 18 and 25 years old at the time of application.
Language Proficiency:
English-Taught Programs: A minimum IELTS score of 6.0 or TOEFL score of 80 is typically required.
Chinese-Taught Programs: An HSK Level 5 certificate is preferred.
Health Requirements: Applicants must be in good physical and mental health, as verified by a medical examination.
Criminal Record: A certificate of no criminal record is required to ensure the applicant's good conduct.
Financial Proof: Applicants must provide evidence of sufficient financial resources to cover tuition and living expenses during their studies in China.
Know more
In 2023, AMU achieved a significant breakthrough in the treatment of spinal cord injuries. A team of researchers successfully developed a bioelectronic implant that accelerates nerve regeneration in damaged spinal tissues. This achievement is set to revolutionize treatments for spinal cord injuries, offering hope to thousands of individuals suffering from paralysis. The device, made from biocompatible materials, uses electrical stimulation to promote nerve growth and restore some motor functions. The research conducted by AMU has paved the way for future advancements in neuroregenerative medicine and spinal injury treatments, marking a major milestone in medical science.
In 2022, AMU introduced an AI-powered diagnostic platform that helps healthcare professionals analyze medical images with higher precision and efficiency. The platform uses machine learning algorithms to evaluate MRI, CT scans, and X-rays, identifying anomalies such as tumors or fractures. This technology significantly reduces the time needed for diagnoses and enhances accuracy, improving overall patient outcomes. The development of this platform marks AMU’s commitment to combining artificial intelligence with healthcare to provide more accurate and faster diagnostics, especially in remote areas lacking skilled radiologists. The platform has the potential to transform the medical imaging industry globally.
In 2021, AMU's research team introduced a non-invasive glucose monitoring device, a game-changer for individuals living with diabetes. This innovative device uses infrared technology to measure glucose levels without the need for blood samples. It provides continuous, real-time glucose data, which allows for better disease management and a more comfortable experience for patients. The development of this device reduces the discomfort and inconvenience associated with traditional blood glucose monitoring methods. This achievement exemplifies AMU’s dedication to improving the quality of life for diabetics and advancing medical technologies that eliminate the need for invasive procedures.
In 2020, AMU made significant progress in regenerative medicine, developing an advanced tissue scaffold for burn victims. This scaffold, made from biodegradable and biocompatible materials, stimulates tissue regeneration and accelerates the healing process in burn victims, reducing scarring and enhancing recovery. This achievement is especially important for patients with third-degree burns or extensive skin damage. The tissue scaffold not only improves healing times but also promotes the growth of new skin and blood vessels in the damaged area. It is a promising solution in the field of burn treatment and has the potential to save lives and reduce long-term suffering
In 2019, AMU achieved a milestone in oncology by developing a novel class of nanoparticles capable of detecting cancer at its earliest stages. These nanoparticles target specific cancerous cells and emit a signal that can be easily detected by imaging technologies, offering early detection of cancers such as breast and lung cancer. The breakthrough is crucial as early cancer detection significantly improves treatment outcomes. Additionally, the nanoparticles can be used for targeted drug delivery, reducing the side effects typically associated with cancer treatments. AMU's innovation is a major step forward in the fight against cancer and has the potential to save countless lives.
In 2018, AMU launched a groundbreaking telemedicine platform designed to provide remote healthcare services, particularly in rural and underserved areas. This platform allows doctors to monitor patients' vital signs, conduct consultations, and prescribe treatments remotely, bridging the healthcare gap in remote regions. The system is integrated with wearable medical devices that provide real-time health data, such as blood pressure, heart rate, and oxygen levels. This achievement marks a major advancement in healthcare accessibility, ensuring that patients who otherwise wouldn’t have access to specialized care can receive timely medical attention.
In 2017, AMU’s research team achieved a remarkable breakthrough in gene editing, successfully using CRISPR technology to correct genetic mutations associated with inherited diseases. The achievement focused on conditions like sickle cell anemia and cystic fibrosis. By precisely editing the defective genes, researchers at AMU were able to prevent or even reverse the effects of these genetic disorders. This breakthrough in genetic medicine holds the potential to eradicate genetic diseases at their source and offers hope to patients worldwide who are battling hereditary conditions. AMU’s work is at the forefront of personalized medicine and gene therapy.
AMU achieved a significant breakthrough in renal care in 2016 with the development of a portable dialysis machine. This device, designed for home use, allows patients with kidney failure to undergo dialysis treatments at their convenience, without needing to visit a dialysis center. The machine is compact, lightweight, and easy to operate, offering greater mobility and independence to patients. The invention is expected to revolutionize the way dialysis is administered, making it more accessible and less burdensome for patients with chronic kidney disease. This achievement highlights AMU’s commitment to improving patient care through innovation.
In 2015, AMU made significant contributions to the field of immunology with its research on immune responses to infectious diseases. The university’s team identified new biomarkers that play a key role in the body’s defense mechanisms against diseases like tuberculosis and HIV. This research helped improve vaccine development strategies and offered new insights into how the immune system reacts to infections. The achievement has far-reaching implications for the global fight against infectious diseases, providing valuable data that can aid in the creation of more effective treatments and vaccines. AMU's work in immunology continues to make important strides in global health.
In 2014, AMU developed a cutting-edge biodegradable drug delivery system designed to target specific tissues and organs, thereby reducing side effects typically associated with drug administration. This system uses biodegradable polymers that release drugs over time, ensuring sustained therapeutic effects. The precision of this delivery system ensures that higher concentrations of the drug reach the affected area while minimizing exposure to healthy tissues. This achievement is particularly important in the treatment of cancer, chronic diseases, and inflammatory conditions. AMU’s drug delivery system is a pioneering step towards more efficient and safer therapeutic treatments.
In 2023, researchers at AMU developed an advanced bioelectronic implant designed to enhance nerve regeneration in patients with spinal cord injuries. The implant, made from biocompatible materials, uses electrical stimulation to promote nerve growth and restore motor functions in paralyzed patients. The innovative design not only accelerates the healing process but also significantly reduces the chances of rejection by the immune system, a common issue with traditional implants. This breakthrough could revolutionize the treatment of spinal injuries and other neurodegenerative conditions, offering a new avenue for rehabilitation.
In 2022, AMU researchers introduced a smart insulin delivery system that utilizes a continuous glucose monitor to adjust insulin doses in real-time. The device is equipped with a microchip that communicates with a wearable sensor to monitor blood sugar levels throughout the day. The insulin delivery system is designed to automatically release the required amount of insulin based on the individual's real-time glucose readings, helping diabetics maintain stable blood sugar levels without manual intervention. This innovation represents a significant leap forward in diabetes management and could reduce the risk of long-term complications associated with the disease.
In 2021, AMU researchers invented a novel class of nanoparticles designed for early cancer detection. These nanoparticles can selectively target cancerous cells in the body, attaching to specific biomarkers present only in malignant tissues. Once attached, the nanoparticles emit a signal that can be detected using advanced imaging techniques. This invention promises to significantly improve the early detection of cancers such as breast, lung, and prostate cancer, allowing for faster treatment and better patient outcomes. The nanoparticles are minimally invasive, offering a non-surgical alternative for detecting cancer at its earliest stages.
In 2020, AMU developed a regenerative tissue scaffold designed to repair and replace damaged tissues in patients with severe burns, wounds, or organ damage. The scaffold is composed of biodegradable materials that encourage the growth of new cells and blood vessels, promoting faster healing and minimizing scarring. This scaffold can be tailored to different types of tissue, including skin, muscle, and even heart tissue. It offers a promising solution for individuals suffering from traumatic injuries and could reduce the need for organ transplants in cases of severe tissue damage.
In 2019, researchers at AMU developed an AI-powered diagnostic tool capable of analyzing medical images with unprecedented accuracy. The system uses machine learning algorithms to analyze MRI scans, CT scans, and X-rays, detecting signs of diseases such as tumors, fractures, and infections that may be difficult for human doctors to identify. The AI tool continuously learns from new data, improving its diagnostic abilities over time. This invention has the potential to revolutionize the healthcare industry by providing faster and more accurate diagnoses, especially in underserved regions with limited access to skilled radiologists.
In 2018, AMU introduced an innovative telemedicine platform that enables remote monitoring of patients' health conditions. The platform allows healthcare providers to track vital signs, administer consultations, and prescribe treatments to patients in rural or remote areas without the need for in-person visits. Equipped with wearable devices that track heart rate, blood pressure, and oxygen levels, the platform can detect potential health issues in real-time and alert both patients and doctors. This invention bridges the gap in healthcare accessibility, particularly for underserved populations, and provides timely interventions for chronic disease management.
AMU researchers developed a non-invasive blood glucose sensor in 2017, offering a painless and more convenient way for diabetics to monitor their blood sugar levels. Unlike traditional methods that require blood samples, this sensor uses infrared technology to measure glucose levels through the skin. The device is wearable and provides continuous glucose readings, allowing patients to manage their condition more effectively without the discomfort of finger-pricking. This innovation is particularly beneficial for children and elderly patients who may find traditional glucose monitoring methods challenging or unpleasant.
In 2016, AMU developed a biodegradable drug delivery system that can target specific cells or tissues in the body while minimizing side effects. This system uses biocompatible materials that degrade over time, releasing medication directly at the site of infection or inflammation. The targeted delivery method ensures that higher concentrations of drugs reach the affected area while reducing the risk of systemic side effects, such as gastrointestinal issues or organ damage. The innovation is particularly useful in the treatment of cancer, autoimmune diseases, and chronic inflammatory conditions, offering a more efficient and safer approach to drug administration.
In 2015, AMU researchers introduced a gene editing tool designed to correct mutations that cause genetic diseases. This tool, based on CRISPR technology, allows for precise alterations to an individual's DNA, potentially curing inherited conditions such as cystic fibrosis, sickle cell anemia, and muscular dystrophy. By targeting and repairing defective genes, the tool has the potential to eliminate these conditions at the genetic level, offering hope to millions of people affected by genetic disorders. This breakthrough represents a monumental advancement in genetic medicine and could pave the way for personalized gene therapies in the future.
In 2014, AMU researchers developed a portable dialysis machine aimed at improving the quality of life for patients with kidney failure. Traditional dialysis machines are bulky and require patients to visit specialized centers for treatment. The portable version, designed to be lightweight and compact, allows patients to undergo dialysis in the comfort of their own homes, significantly improving their mobility and independence. The machine provides the same level of efficiency as conventional dialysis units, with automated features that make it easy to operate. This innovation represents a major advancement in renal care and could transform the way dialysis treatment is delivered worldwide.
Embark on your educational journey with confidence! Our team of admission experts is here to guide you through the process. Book a free session now to receive personalized advice, assistance with applications, and insights into your dream school. Whether you're applying to college, graduate school, or specialized programs, we're here to help you succeed.